Notch1, identified through mRNA sequencing of human brain epileptogenic lesion tissue, regulates Th1/Th2 differentiation and recruitment of CD4+ T cells to brain infiltration sites.[18] This study explored the feasibility of Notch1 inhibition as a therapeutic strategy for the treatment of epilepsy. The gene discussed is CD4; the disease is epilepsy.